Jaguar Health IncJAGX
Price$3.95

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $20.3M+815.6% YoYTTM through 31 Mar 2026
Net Income -$34.3MTTM through 31 Mar 2026

Margins

Current
Gross Margin94.1%
Operating Margin50.3%
Net Margin42.9%

Returns

-55.1%ROE
86.1%ROIC

Balance Sheet Health

Debt / Equity-2.10x
Current Ratio0.65x
Net Debt$25.9M
Cash & Equivalents$7.3M

Quality Metrics

Earnings-Beat Rate0.0%

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
Human Health
View details

Targeting NDA submission for rare intestinal failure indications in mid-2027.

Animal Health
View details

Continuing limited activities to collect substantial evidence of effectiveness for full FDA approval.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.